Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Base de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Gastroenterol Hepatol ; 15(8): 931-8, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11022836

RESUMEN

BACKGROUND: Recent studies have suggested that heparin is effective for treatment of inflammatory bowel disease (IBD) and its various effects (in addition to the anticoagulant effect). We evaluated the effects of argatroban as an antithrombin drug on trinitrobenzene sulfonic acid (TNB)-induced colitis, an established model of IBD. METHODS: Rats were randomly assigned to four groups in which mini-osmotic pumps containing saline (TNB-S), argatroban (TNB-A), or 100 U/kg heparin (TNB-H) were intraperitoneally implanted. Three days after the pumps were implanted, TNB was infused via the anus, and colitis was induced. After 5 days, prothrombin time (PT), activated partial prothrombin time (APTT), antithrombin III (AT-III), platelet, fibrinogen, colonic wet weight, macroscopic damage score, histological score, mucosal myeloperoxidase activity and mucosal leukotrien B4 (LTB4) levels were compared among the four groups. RESULTS: The APTT was prolonged in the heparin treatment group but only slightly prolonged in the argatroban treatment group. The platelet count and the fibrinogen level were higher in the TNB-S group than in the healthy control group and the AT-III level was slightly lower in the TNB-S group than in the healthy control group and lower still in the TNB-H group. CONCLUSIONS: The colonic wet weight was similar among the four groups while the macroscopic damage score, histological score, mucosal myeloperoxidase activity and the mucosal LTB4 level were significantly decreased in the TNB-A and TNB-H groups. Argatroban, as well as heparin may be effective for treatment of TNB-induced colitis.


Asunto(s)
Antitrombinas/uso terapéutico , Colitis/tratamiento farmacológico , Ácidos Pipecólicos/uso terapéutico , Análisis de Varianza , Animales , Arginina/análogos & derivados , Pruebas de Coagulación Sanguínea , Colitis/sangre , Colitis/inducido químicamente , Modelos Animales de Enfermedad , Heparina/farmacología , Técnicas para Inmunoenzimas , Bombas de Infusión Implantables , Leucotrieno B4/metabolismo , Masculino , Nitrobencenos , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Sulfonamidas , Ácidos Sulfónicos
2.
Pancreas ; 20(4): 373-7, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10824691

RESUMEN

Basic fibroblast growth factor (bFGF) is one of the mitogens that facilitate endothelial proliferation and angiogenesis. This study was designed to examine the therapeutic effect of bFGF on experimental pancreatitis in rat. Edematous pancreatitis was induced by intraperitoneal injections of cerulein (50 microg/kg) at hourly intervals. BFGF (70 nmol/kg) was administered intraperitoneally after induction of pancreatitis. DNA synthesis of isolated pancreatic acinar cells of normal rats was determined as the uptake of 5-bromo-2'-deoxyuridine (BrdU) into the cells. Immunohistochemical staining of DNA synthesis in acinar cells during cerulein-induced pancreatitis was also examined with BrdU labeling in vivo technique. Cerulein administration increased serum amylase, lipase level, and wet weight of pancreatic tissue. Treatment with bFGF markedly ameliorated all these parameters. In primary culture system of isolated pancreatic acinar cells of normal rats, bFGF caused a dose-dependent increase in BrdU incorporation into DNA, showing an EC50 value of 0.8 nmol/L and a maximum response of 2.5-fold increase at a concentration of 400 nmol/L. bFGF treatment (70 nmol/kg) markedly increased BrdU labeling in the nucleus of acinar cells of the pancreatitis rats group in immunohistochemical examination when compared with control without bFGF treatment. Treatment with bFGF may represent a promising therapeutic concept for patients with acute pancreatitis.


Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/uso terapéutico , Pancreatitis/tratamiento farmacológico , Animales , Bromodesoxiuridina/metabolismo , División Celular , Ceruletida/administración & dosificación , ADN/biosíntesis , Edema/tratamiento farmacológico , Inmunohistoquímica , Masculino , Pancreatitis/inducido químicamente , Pancreatitis/patología , Ratas , Ratas Wistar
3.
Endoscopy ; 32(4): 294-9, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10774968

RESUMEN

BACKGROUND AND STUDY AIMS: The mechanism of Helicobacter pylori-induced gastric mucosal injury is unknown, but H. pylori infection is conducive to accumulation in the stomach of monochloramine, a cytotoxic substance. The present study involved morphological investigation of the damaging effects of monochloramine on rat gastric mucosa, using endoscopic observations through a gastric fistula. The study also examined the protective effect of taurine against monochloramine-induced gastric mucosal lesions in rats. MATERIALS AND METHODS: The effects of monochloramine in rats were studied by administering the substance via a gastrostomy, which was then used to conduct a series of endoscopic observations. Local blood flow was measured using a laser Doppler method. Histological examination was carried out after 24 hours. Various monochloramine concentrations were used, and some animals were pretreated with taurine, a monochloramine scavenger, via the gastrostomy. RESULTS: Endoscopically, monochloramine was found to produce hemorrhagic mucosal erosions, mainly in the gastric body, in a time-dependent and concentration-dependent manner. Blood flow was decreased in advance of mucosal erosion. Taurine prevented mucosal injury by 30 mM monochloramine, the highest concentration tested. CONCLUSIONS: Although only the first 24 hours of mucosal injury were observed in the present study, the most likely mechanisms by which monochloramine caused injury to the gastric mucosa appeared to be both oxidative damage and a reduction in blood flow, impairing the mucosal defense mechanism.


Asunto(s)
Cloraminas/farmacología , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Gastroscopía/métodos , Taurina/farmacología , Análisis de Varianza , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Mucosa Gástrica/irrigación sanguínea , Gastrostomía , Masculino , Probabilidad , Ratas , Ratas Wistar , Valores de Referencia , Flujo Sanguíneo Regional
4.
Scand J Gastroenterol ; 34(11): 1117-22, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10582763

RESUMEN

BACKGROUND: The aim of this study was to assess the effect of aminoguanidine (AG) on developed colitis and cell proliferation. METHODS: Colitis was induced by means of trinitrobenzene sulphonic acid (TNB) in male Wistar rats weighing about 250 g. Seven days after induction of TNB colitis the rats were divided into two groups at random, and one group was orally treated with 1.5 micromol/kg AG each day. We assessed the effect of AG by measuring the mucosal damage, the ulcer area, myeloperoxidase (MPO) activity, inducible nitric oxide synthase (iNOs) activity, and nitrogen oxide in serum 7 days after the beginning of treatment. RESULTS: AG significantly ameliorated the macroscopic damage score (AG versus control, 5.25 +/- 0.80 versus 7.50 +/- 0.50), the microscopic damage score (5.88 +/- 1.13 versus 9.25 +/- 0.31), ulcer area (0.57 +/- 0.14 versus 1.24 +/- 0.17 cm2), decreased MPO activity (51.5 +/- 9.4 versus 192.2 +/- 60 units/g tissue), and nitrogen oxide in serum (27.2 +/- 1.4 versus 32.3 +/- 1.8 microM) but did not decrease iNOs activity (8732 +/- 435 versus 8672 +/- 357 cpm/g tissue). Moreover, AG accelerated T84 cell proliferation in a dose-dependent manner. CONCLUSIONS: These results suggest that AG ameliorates TNB colitis not only by its anti-inflammatory effect but also by accelerating the proliferation of colonic mucosal cells. AG, accordingly, might well be a useful new medicine to ameliorate inflammatory bowel disease.


Asunto(s)
Colitis/tratamiento farmacológico , Colitis/enzimología , Inhibidores Enzimáticos/farmacología , Guanidinas/farmacología , Mucosa Intestinal/enzimología , Análisis de Varianza , Animales , Células Epiteliales/efectos de los fármacos , Mucosa Intestinal/citología , Mucosa Intestinal/efectos de los fármacos , Masculino , Óxido Nítrico Sintasa/metabolismo , Óxidos de Nitrógeno/metabolismo , Peroxidasa/metabolismo , Ratas , Ratas Wistar , Ácido Trinitrobencenosulfónico
5.
Am J Chin Med ; 27(3-4): 347-54, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10592843

RESUMEN

Ginseng radix (GR) is often used in traditional Japanese kampo medicine. We studied the effect of GR on glucose and maltose transport in rat and human duodenal mucosa by Ussing's method, and on smooth muscle movement in rat duodenal muscle by Magnus' method. GR inhibited absorption of glucose or maltose in rat and human duodenal mucosa, but increased duodenal muscle movement. It suggests that the inhibition of sugar absorption by GR is more dominant than enhancement of duodenal muscle movement by GR.


Asunto(s)
Glucosa/farmacocinética , Absorción Intestinal/efectos de los fármacos , Maltosa/farmacocinética , Panax , Plantas Medicinales , Adulto , Animales , Femenino , Humanos , Técnicas In Vitro , Indicadores y Reactivos , Mucosa Intestinal/efectos de los fármacos , Masculino , Persona de Mediana Edad , Músculo Liso/efectos de los fármacos , Peristaltismo/efectos de los fármacos , Ratas , Ratas Wistar
6.
J Pharmacol Exp Ther ; 290(3): 1080-4, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10454480

RESUMEN

Troglitazone is a new, orally effective antidiabetic agent that decreases plasma glucose in obese patients with non-insulin-dependent diabetes mellitus. Unfortunately, troglitazone also has a propensity to cause edema. This study was designed to determine how troglitazone affects intestinal ion transport and water absorption. Short circuit current (I(sc)) was measured in rat and human duodenal mucosa in Ussing chambers. Five minutes later, the serosal addition of troglitazone caused I(sc) to decrease gradually, and after 50 min, I(sc) reached the peak of decrease. EC(50) values and maximum response to I(sc) in rat and human mucosa were 8.4 and 8.7 microM and 8.56 +/- 1.0 and 8.00 +/- 2.0 microA/cm(2), respectively. In an HCO(3)(-)/CO(2)-free system, the decrease in I(sc) caused by troglitazone was 1.31 +/- 0.83 microA/cm(2). When 10 mM acetazolamide was preadministered, the small decrease in I(sc) evoked by troglitazone (20 microM) was 4.56 +/- 0.22 microA/cm(2), whereas the preadministration of 100 microM amiloride and 100 nM tetrodotoxin did not influence the decrease in I(sc) evoked by troglitazone. The serosal preadministration of 100 nM vasoactive intestinal peptide potently enhanced the decrease in I(sc) evoked by 20 microM troglitazone (21.1 +/- 1.63 microA/cm(2)). The cyclic AMP contents of rat duodenal mucosa incubated with and without troglitazone (20 microM) for 50 min were 3.2 +/- 0.25 and 5. 8 +/- 0.46 pmol/mg protein, respectively (P <.01). These results indicate that the ionic basis for the decrease in I(sc) that is induced by troglitazone may be inhibition of electrogenic bicarbonate secretion. The alteration of intestinal ion transport by troglitazone could cause edema.


Asunto(s)
Bicarbonatos/metabolismo , Cromanos/farmacología , Duodeno/efectos de los fármacos , Duodeno/metabolismo , Hipoglucemiantes/farmacología , Secreciones Intestinales/efectos de los fármacos , Secreciones Intestinales/metabolismo , Tiazoles/farmacología , Tiazolidinedionas , Animales , Transporte Biológico/efectos de los fármacos , Cromanos/efectos adversos , AMP Cíclico/metabolismo , Duodeno/fisiología , Humanos , Hipoglucemiantes/efectos adversos , Técnicas In Vitro , Absorción Intestinal/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/fisiología , Secreciones Intestinales/fisiología , Masculino , Ratas , Ratas Wistar , Tiazoles/efectos adversos , Troglitazona , Agua/metabolismo
7.
Peptides ; 20(1): 127-32, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10098633

RESUMEN

We have investigated the effect of adrenomedullin (AM) on restitution of mucosal integrity following damage in rat and human gastric mucosa, measuring the potential difference (PD) on a mucosal strip mounted on an Ussing chamber. Mucosal damage was induced by 0.5, 1.0, and 2.0 M NaCl solution, and it caused an immediate and significant decrease in PD. In the rat AM group, PD recovered significantly more than in control group at 120 min after exposure to 0.5 M (p < 0.01) and 1.0 M (p < 0.05) NaCl solution. In the human AM group, PD completely recovered at 120 min after exposure to 0.5 M (p < 0.05) NaCl solution. In rat mucosa damaged by 0.5 M NaCl solution, the effect was inhibited by human (h)-CGRP(8-37) and there was no significant difference between the h-CGRP(8-37) group and control group. On immunohistochemical examination of rat gastric mucosa, AM was detected within the chief cell. AM probably promotes epithelial restitution primarily through the CGRP receptor, but it does not ameliorate more severe damage of gastric mucosa in vitro.


Asunto(s)
Mucosa Gástrica/efectos de los fármacos , Péptidos/farmacología , Receptores de Péptidos , Adrenomedulina , Animales , Péptido Relacionado con Gen de Calcitonina/farmacología , Reacciones Cruzadas , Células Epiteliales/efectos de los fármacos , Células Epiteliales/fisiología , Mucosa Gástrica/fisiología , Humanos , Inmunohistoquímica , Masculino , Proteínas de la Membrana/análisis , Proteínas de la Membrana/metabolismo , Ratas , Ratas Wistar , Receptores de Adrenomedulina , Receptores de Péptido Relacionado con el Gen de Calcitonina/análisis , Receptores de Péptido Relacionado con el Gen de Calcitonina/metabolismo
8.
Dig Dis Sci ; 43(11): 2526-35, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9824146

RESUMEN

Effects of okadaic acid (OA) on mucosal damage were examined in rat colon. OA was sprinkled on rat colon mucosa under observation with an electronic-endoscopic system, and OA was also applied to the in vivo microscopic field. The OA-induced changes in transepithelial conductance (Gt) were measured by the Ussing voltage clamp technique. By endoscopic observation, the luminal sprinkling of OA (60 nmol/kg) evoked transient microthrombi in the submucosal venule, which was followed by mucosal edema. Histological study after endoscopic observation showed submucosal fluid retention, suggesting an increase of vascular permeability. The microthrombi were also detected by in vivo microscopy. By electrophysiological study after endoscopic observation with and without OA addition, the basal Gt values were 54+/-6.2 and 36.2+/-4.2 mS/cm2, respectively (P < 0.01). Furthermore in control rats, the serosal addition of OA evoked an increase in Gt in a concentration-dependent manner without increasing lactate dehydrogenase release. 2,4,6-Triaminopyrimidinium inhibited OA-induced Gt change by 60%. These results indicate that OA evokes an increase in paracellular permeability of epithelium. We conclude that the developed microthrombi are the first key event of OA-induced mucosal damage, followed by an increase in permeability in the submucosal venule and in the paracellular pathway of the epithelium.


Asunto(s)
Colon/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Ácido Ocadaico/farmacología , Animales , Colon/anatomía & histología , Colon/enzimología , Colon/fisiología , Colonoscopía/métodos , Diarrea/inducido químicamente , Conductividad Eléctrica , Inhibidores Enzimáticos/administración & dosificación , Mucosa Intestinal/anatomía & histología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/enzimología , Mucosa Intestinal/fisiología , L-Lactato Deshidrogenasa/efectos de los fármacos , Masculino , Microscopía/métodos , Ácido Ocadaico/administración & dosificación , Ratas , Ratas Wistar , Trombosis/inducido químicamente , Factores de Tiempo
9.
Peptides ; 19(6): 1043-7, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9700753

RESUMEN

We have investigated the effects of adrenomedullin (AM) on mucosal ion transport using the Ussing method and smooth muscle contraction using the Magnus method in rat. Our results indicate that AM increases Isc (short-circuit current) for Cl- secretion (100 nM:170.0 +/- 41.2%, 1 microM:193.8 +/- 45.5%, 100% Isc:28.2 +/- 3.1 microA/cm2) with an initial small decrease of Isc, inhibiting Na+ absorption. Tetrodotoxin (TTX) inhibits the Isc response elicited by AM (86%). In addition, AM relaxes potassium-induced contraction (10 nM:11.1 +/- 8.51%, 100 nM:33.4 +/- 12.7%, 100% contraction: 1.8 +/- 0.22 g), and TTX inhibits the response elicited by AM (90%). We conclude that AM modulates water and ion transport as well as bowel movement, mainly through the colonic nervous system.


Asunto(s)
Colon/efectos de los fármacos , Contracción Muscular/efectos de los fármacos , Péptidos/farmacología , Vasodilatadores/farmacología , Adrenomedulina , Animales , Cloruros/metabolismo , Colon/metabolismo , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Masculino , Ratas , Ratas Wistar , Sodio/metabolismo , Tetrodotoxina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA